Novartis Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 42,584.0 | 38,947.0 | 36,749.0 |
| Cost of Goods Sold | 11,439.0 | 11,032.0 | 10,299.0 |
| Gross Profit | 31,145.0 | 27,915.0 | 26,450.0 |
| Gross Profit Margin | 73.1% | 71.7% | 72.0% |
| SG&A Expense | 14,097.0 | 13,259.0 | 12,411.0 |
| Depreciation & Amortization | -- | -- | 2,026.0 |
| Operating Income | 9,789.0 | 7,724.0 | 8,567.0 |
| Operating Margin | 23.0% | 19.8% | 23.3% |
| Nonoperating Income | (867.0) | 943.0 | 618.0 |
| Nonoperating Expenses | 94.0 | -- | -- |
| Income Before Taxes | 9,499.0 | 7,487.0 | 8,301.0 |
| Income Taxes | 1,336.0 | 947.0 | 1,282.0 |
| Net Income After Taxes | 8,163.0 | 6,540.0 | 7,019.0 |
| Continuing Operations | 8,163.0 | 6,540.0 | 7,019.0 |
| Discontinued Operations | 70.0 | 5,428.0 | 183.0 |
| Total Operations | 8,233.0 | 11,968.0 | 7,202.0 |
| Total Net Income | 8,233.0 | 11,968.0 | 7,202.0 |
| Net Profit Margin | 19.3% | 30.7% | 19.6% |
| Diluted EPS from Total Net Income ($) | 3.59 | 5.13 | 3.04 |
| Dividends per Share | 1.54 | 1.10 | 0.89 |
© 2009 Morningstar, Inc. Financial Data provided by
